{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:12:28Z","timestamp":1774084348963,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6900,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1023\/a:1008354323167","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"249-254","source":"Crossref","is-referenced-by-count":145,"title":["Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases"],"prefix":"10.1016","volume":"12","author":[{"given":"C.","family":"Christodoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Karabelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bacoyiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.V.","family":"Skarlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008354323167_bb0010","series-title":"Cancer: Principles & Practice of Oncology","first-page":"2523","article-title":"Treatment of metastatic cancer","author":"Loeffler","year":"1997"},{"key":"10.1023\/A:1008354323167_bb0015","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U","article-title":"Brain metastases. Histology, mutliplicity, surgery, survival","volume":"78","author":"Nussbaum","year":"1996","journal-title":"Cancer"},{"key":"10.1023\/A:1008354323167_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","article-title":"Identification of prognostic factors in patients with brain metastases: A review of 1292 patients","volume":"43","author":"Lagerwaard","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0360-3016(00)00547-2","article-title":"Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases","volume":"47","author":"Gaspar","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0360-3016(99)00416-2","article-title":"Prognostic factors in brain metastases. Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?","volume":"46","author":"Nieder","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0360-3016(98)00198-9","article-title":"Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases","volume":"42","author":"Agboola","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.1993.79.2.0210","article-title":"Surgical treatment of multiple brain metastases","volume":"79","author":"Bindal","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1023\/A:1008354323167_bb0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0360-3016(94)90558-4","article-title":"The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age","volume":"29","author":"Noordijk","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008354323167_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0360-3016(96)85008-5","article-title":"A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis","volume":"35","author":"Auchter","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0360-3016(92)90567-2","article-title":"The role of radiation therapy in the treatment of brain metastases","volume":"23","author":"Coia","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.39.6.789","article-title":"Radiation-induced dementia in patients cured of brain metastases","volume":"39","author":"DeAngelis","year":"1989","journal-title":"Neurology"},{"key":"10.1023\/A:1008354323167_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0360-3016(94)00655-5","article-title":"Radiation response of the central nervous system","volume":"31","author":"Schultheiss","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0075","first-page":"3163","article-title":"Penetration of N-(phosphonacetyl)-l-aspartate into human central nervous system and intracerebral tumor","volume":"40","author":"Stewart","year":"1980","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0080","first-page":"2474","article-title":"Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors","volume":"42","author":"Stewart","year":"1982","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000227562","article-title":"Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide","volume":"53","author":"Malacarne","year":"1996","journal-title":"Oncology"},{"key":"10.1023\/A:1008354323167_bb0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1200\/JCO.1989.7.7.916","article-title":"Primary chemotherapy of brain metastasis in small-cell lung cancer","volume":"7","author":"Lee","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008354323167_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-5002(99)00071-9","article-title":"Concomitant brain radiotherapy and vinorelbine\u2013ifosfamide\u2013cisplatin chemotherapy in brain metastases of non-small-cell lung cancer","volume":"26","author":"Quantin","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1023\/A:1008354323167_bb0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/1097-0142(19920215)69:4<972::AID-CNCR2820690423>3.0.CO;2-P","article-title":"Response of brain metastases from breast cancer to systemic chemotherapy","volume":"69","author":"Boogerd","year":"1992","journal-title":"Cancer"},{"key":"10.1023\/A:1008354323167_bb0105","first-page":"2853","article-title":"Activity of temozolomide in the treatment of central nervous system tumor xenografts","volume":"55","author":"Friedman","year":"1995","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0110","first-page":"3793","article-title":"Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea","volume":"54","author":"Plowman","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0115","first-page":"5846","article-title":"Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methylimidazo[5,l-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine","volume":"47","author":"Stevens","year":"1987","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/bjc.1992.57","article-title":"Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)","volume":"65","author":"Newlands","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008354323167_bb0125","first-page":"309","article-title":"Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer","volume":"5","author":"Baker","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008354323167_bb0130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.1995.13.4.910","article-title":"Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma","volume":"13","author":"Bleehen","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008354323167_bb0135","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0959-8049(96)00258-4","article-title":"The Charing Cross Hospital experience with temozolomide in patients with gliomas","volume":"32A","author":"Newlands","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008354323167_bb0140","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","article-title":"Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group","volume":"17","author":"Yung","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008354323167_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008354323167_bb0150","series-title":"WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48","year":"1979"},{"key":"10.1023\/A:1008354323167_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1023\/A:1008354323167_bb0160","series-title":"Cancer: Principles & Practice of Oncology","first-page":"2022","article-title":"Neoplasms of the central nervous system","author":"Levin","year":"1997"},{"key":"10.1023\/A:1008354323167_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-5002(98)00021-X","article-title":"Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small-cell lung cancer","volume":"20","author":"Minotti","year":"1998","journal-title":"Lung Cancer"},{"key":"10.1023\/A:1008354323167_bb0170","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.0.CO;2-#","article-title":"Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, non-small-cell lung carcinoma, or malignant melanoma: A prospective study","volume":"85","author":"Franciosi","year":"1999","journal-title":"Cancer"},{"key":"10.1023\/A:1008354323167_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008354323167_bb0180","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/carcin\/10.9.1681","article-title":"Inactivation of O6-alkylguanine-DNA alkyltransferase in HeLa cells by cisplatin","volume":"10","author":"Wang","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1023\/A:1008354323167_bb0185","first-page":"1629","article-title":"A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies","volume":"5","author":"Britten","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419472943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419472943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/2\/249\/19479277\/12-2-249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:57:10Z","timestamp":1582181830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419472943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0923753419472943"],"URL":"https:\/\/doi.org\/10.1023\/a:1008354323167","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}